EU Vaccine Strategy
Datum der Veranstaltung: 07/01/2021
Vaccines are a key part of a long-term strategy to bring SARS-CoV-2 under control. It is essential to rollout vaccination rapidly to protect as many people as possible and to lower the opportunities for the virus to evolve further. Any vaccine must be authorised by the European Medicines Agency (EMA).
The European Commission has secured up to 2,6 billion doses of vaccines so far and the vaccination in the EU is progressing. However, countries are facing challenges around the limited vaccine supply, disinformation or vaccine acceptance. The European Parliament is trying to keep an eye on the purchase and safety of these vaccines. In the meantime, the EU is also preparing the Digital Green Certificate to facilitate the safe free movement of citizens within the EU during the pandemic. The certificate could include information on whether a traveller has been vaccinated against COVID-19, a COVID-19 test result, and information on recovery from a COVID-19 infection. It should be based on a strict respect for non-discrimination and of the fundamental rights of EU citizens. The legislation should be adopted in the EP by June.